Travere Therapeutics, Inc. (TVTX)

NASDAQ: TVTX · Real-Time Price · USD

47.18

-0.58 (-1.21%)

At close: May 29, 2026, 4:00 PM EDT

46.80

-0.38 (-0.81%)

After-hours: May 29, 2026, 7:43 PM EDT

Travere Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	536.2	490.73	233.18	145.24	109.46	131.84
Revenue Growth (YoY)	96.03%	110.45%	60.55%	32.69%	-16.97%	-33.52%
Cost of Revenue	7.61	10.34	7.74	11.45	4.42	3.82
Gross Profit	528.59	480.39	225.43	133.79	105.04	128.02
Selling, General & Admin	344.62	337.2	264.12	265.54	197.52	126.28
Research & Development	216.22	206.01	217.5	244.99	227.33	201.16
Other Operating Expenses	24.82	-	67.64	11.39	-	-
Total Operating Expenses	585.65	543.21	549.26	521.93	424.85	327.44
Operating Income	-57.06	-62.82	-323.83	-388.14	-319.81	-199.43
Interest Income	11.51	12.72	17.82	21.77	6.28	1.99
Interest Expense	-10.19	-10.75	-11.18	-11.33	-11.01	-19.68
Other Non-Operating Income (Expense)	10.94	11.58	-3.32	1.59	-6.6	0.23
Total Non-Operating Income (Expense)	12.25	13.55	3.32	12.03	-11.34	-17.46
Pretax Income	-44.81	-49.27	-320.51	-376.11	-331.16	-216.88
Provision for Income Taxes	0.82	0.99	0.12	0.22	0.31	0.41
Net Income	-21.42	-25.55	-321.55	-111.4	-278.48	-180.09
Earnings From Discontinued Operations	24.22	24.72	-0.92	264.93	52.99	37.2
Net Income to Common	-21.42	-25.55	-321.55	-111.4	-278.48	-180.09
Shares Outstanding (Basic)	90	89	79	74	64	60
Shares Outstanding (Diluted)	93	89	79	74	64	60
Shares Change (YoY)	14.38%	13.08%	6.22%	16.48%	6.56%	25.86%
EPS (Basic)	-0.22	-0.29	-4.08	-1.50	-4.37	-3.01
EPS (Diluted)	-0.23	-0.29	-4.08	-1.50	-4.37	-3.01
Shares Outstanding	92.4	90.92	87.45	75.37	64.29	62.49
Free Cash Flow	39.49	37.78	-237.48	-280.02	-186.29	-19.89
Free Cash Flow Growth	4.53%	-	-	-	-	-
Free Cash Flow Per Share	0.42	0.42	-3.01	-3.77	-2.92	-0.33
Gross Margin	98.58%	97.89%	96.68%	92.12%	95.96%	97.10%
Operating Margin	-10.64%	-12.80%	-138.88%	-267.24%	-292.17%	-151.27%
Profit Margin	-6.92%	-10.24%	-137.51%	-259.12%	-302.82%	-164.82%
FCF Margin	7.37%	7.70%	-101.84%	-192.80%	-170.19%	-15.09%
EBITDA	16.09	-2.08	-280.27	-349.61	-299.09	-186.68
EBITDA Margin	3.00%	-0.42%	-120.20%	-240.71%	-273.25%	-141.60%
EBIT	-57.06	-62.82	-323.83	-388.14	-319.81	-199.43
EBIT Margin	-10.64%	-12.80%	-138.88%	-267.24%	-292.17%	-151.27%
Effective Tax Rate	-1.83%	-2.01%	-0.04%	-0.06%	-0.09%	-0.19%

SEC Filings: 10-K · 10-Q